A recent retrospective multicenter cohort study utilizing the Tianjin Health and Medical Big Data Super Platform has revealed critical insights into glycemic management for older adults with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). The study analyzed longitudinal HbA1c trajectories in a cohort of 2,037 older adults compared to 6,075 younger controls, employing group-based trajectory modeling (GBTM) to elucidate glycemic-mortality associations.

The findings underscore the distinct glycemic-mortality patterns between older and younger adults. Over a median follow-up of 4.56 years, the study identified three key trajectories in older adults: Low-stable (mean HbA1c 5.12%), Medium-declining (6.62%), and High-stable (8.50%). Notably, while both the High-stable and Medium-declining trajectories were linked to increased mortality risk in younger adults, only the High-stable trajectory (HR 1.73, P = 0.006) posed a significant risk in older adults. Importantly, maintaining HbA1c levels between 6.5% and 8% was associated with optimal survival outcomes, while sustained hyperglycemia exceeding 8% significantly elevated mortality risk (HR 1.75, P = 0.021).

These results advocate for individualized glycemic targets in older adults with T2DM and CKD, suggesting that a more relaxed HbA1c range may balance survival benefits against treatment burdens. This research could shift current paradigms in diabetes management, emphasizing the need for tailored therapeutic approaches that consider the unique physiological responses of older patients. As a result, this study may influence future clinical guidelines and drug development timelines, focusing on interventions that effectively mitigate hyperglycemia-related risks in this vulnerable population.

Source: academic.oup.com